Obinutuzumab in two patients suffering from immune‐mediated thrombotic thrombocytopenic purpura intolerant to rituximabJudith Robertz, Johanna A. Kremer Hovinga, Martin Andres et al.|American Journal of Hematology|2019Cited by 13